{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T19:44:57Z","timestamp":1770752697417,"version":"3.50.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1993,8,1]],"date-time":"1993-08-01T00:00:00Z","timestamp":744163200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[1993,8]]},"DOI":"10.1007\/bf01788127","type":"journal-article","created":{"date-parts":[[2005,6,19]],"date-time":"2005-06-19T22:29:54Z","timestamp":1119220194000},"page":"57-62","source":"Crossref","is-referenced-by-count":49,"title":["Primary thrombocythemia: diagnosis, clinical manifestations and management"],"prefix":"10.1007","volume":"67","author":[{"given":"P. J. J.","family":"van Genderen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. J.","family":"Michiels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF01788127_CR1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0002-9343(92)90017-6","volume":"92","author":"Anagrelide Study Group","year":"1992","unstructured":"Anagrelide Study Group (1992) Anagrelide, a therapy for thrombocythemic states: experience in 577 patients. Am J Med 92:69\u201376","journal-title":"Am J Med"},{"key":"BF01788127_CR2","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/ajh.2830330217","volume":"33","author":"PJ Anker-Lugtenburg van den","year":"1990","unstructured":"Anker-Lugtenburg PJ van den, Sizoo W (1990) Myelodys-plastic syndrome and secondary acute leukemia after treatment of essential thrombocythemia with hydroxyurea. Am J Hematol 33:152","journal-title":"Am J Hematol"},{"key":"BF01788127_CR3","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/0277-5379(83)90091-3","volume":"19","author":"T Barbui","year":"1983","unstructured":"Barbui T, Cortelazzo S, Viero P, Bassan R, Dini E, Semeraros N (1983) Thrombohaemorrhagic complications in 101 cases of myeloproliferative disorders: relationship to platelet number and function. Eur J Cancer Clin Oncol 19:1593\u20131599","journal-title":"Eur J Cancer Clin Oncol"},{"key":"BF01788127_CR4","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0002-9343(87)90696-6","volume":"83","author":"T Barbui","year":"1987","unstructured":"Barbui T, Buelli M, Cortelazzo S, Viero P, De Gaetano G (1987) Aspirin and the risk of bleeding in patients with thrombocythemia. Am J Med 83:265\u2013268","journal-title":"Am J Med"},{"key":"BF01788127_CR5","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1365-2141.1991.tb08586.x","volume":"77","author":"J Beard","year":"1991","unstructured":"Beard J, Hillmen P, Anderson CC, Lewis SM, Pearson TC (1991) Primary thrombocythemia in pregnancy. Br J Haematol 77:371\u2013374","journal-title":"Br J Haematol"},{"key":"BF01788127_CR6","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1002\/1097-0142(19861201)58:11<2440::AID-CNCR2820581115>3.0.CO;2-Y","volume":"58","author":"S Bellucci","year":"1986","unstructured":"Bellucci S, Janvier M, Tobelem G, Flandrin G, Charpak Y, Berger R, Boiron M (1986) Essential thrombocythemias: clinical, evolutionary and biological data. Cancer 58:2440\u20132447","journal-title":"Cancer"},{"key":"BF01788127_CR7","doi-asserted-by":"crossref","unstructured":"Bellucci S, Harousseau JL, Brice P, Tobelem G (1988) Treatment of essential thrombocythemia by alpha 2a interferon. Lancet 960\u2013961","DOI":"10.1016\/S0140-6736(88)92625-6"},{"key":"BF01788127_CR8","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1056\/NEJM198102193040801","volume":"303","author":"PD Berk","year":"1981","unstructured":"Berk PD, Goldberg JD, Silverstein MN et al (1981) Increased incidence of acute leukemia in polycythemia vera associated with chlorambucil treatment. N Engl J Med 303:441\u2013447","journal-title":"N Engl J Med"},{"key":"BF01788127_CR9","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1182\/blood.V64.5.981.981","volume":"64","author":"U Budde","year":"1984","unstructured":"Budde U, Sch\u00e4fer G, M\u00fcller N, Eyk H, Dent J, Ruggeri Z, Zimmerman T (1984) Acquired von Willebrand's disease in the myeloproliferative syndrome. Blood 64:981\u2013985","journal-title":"Blood"},{"key":"BF01788127_CR10","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1182\/blood.V68.6.1213.1213","volume":"68","author":"U Budde","year":"1986","unstructured":"Budde U, Dent JA, Berkowitz DS, Ruggeri ZM, Zimmerman THS (1986) Composition of plasma von Willebrand factor in patients with the myeloproliferative syndrome. Blood 68:1213\u20131217","journal-title":"Blood"},{"key":"BF01788127_CR11","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0344-0338(84)80124-7","volume":"179","author":"R Burkhardt","year":"1984","unstructured":"Burkhardt R, Bartl R, Jager K, Frisch B, Kettner G, Mahl G, Sund M (1984) Chronic myeloproliferative disorders (CMPD). Pathol Res Pract 179:131\u2013186","journal-title":"Pathol Res Pract"},{"key":"BF01788127_CR12","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/ajh.2830200408","volume":"20","author":"DH Buss","year":"1985","unstructured":"Buss DH, Stuart JJ, Lipscomb GE (1985) The incidence of thrombotic and hemorrhagic disorders in association with extreme thrombocytosis: an analysis of 129 cases. Am J Hematol 20:365\u2013372","journal-title":"Am J Hematol"},{"key":"BF01788127_CR13","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1002\/1097-0142(19910601)67:11<2926::AID-CNCR2820671136>3.0.CO;2-3","volume":"67","author":"M Colombi","year":"1991","unstructured":"Colombi M, Radaelli F, Zocchi L, Maiolo AT (1991) Thrombotic and hemorrhagic complications in essential thrombocythemia: a retrospective study of 103 patients. Cancer 67:2926\u20132930","journal-title":"Cancer"},{"key":"BF01788127_CR14","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1200\/JCO.1990.8.3.556","volume":"8","author":"S Cortelazzo","year":"1990","unstructured":"Cortelazzo S, Viero P, Finazzi G, D'Emilio A, Rodeghiero F, Barbui T (1990) Incidence and risk factors for thrombotic complications in a historical cohort of 100 patients with essential thrombocythemia. J Clin Oncol 8:556\u2013562","journal-title":"J Clin Oncol"},{"key":"BF01788127_CR15","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/BF01891529","volume":"293","author":"E Epstein","year":"1934","unstructured":"Epstein E, Goebel A (1934) H\u00e4morrhagische Thrombocyth\u00e4mie bei vascul\u00e4rer Schrumpfmilz. Virchows Arch 293:233\u2013247","journal-title":"Virchows Arch"},{"key":"BF01788127_CR16","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/1097-0142(19900801)66:3<549::AID-CNCR2820660324>3.0.CO;2-6","volume":"66","author":"P Fenaux","year":"1990","unstructured":"Fenaux P, Simon M, Caulier MT, Lai JL, Goudemand J, Bauters F (1990) Clinical course of essential thrombocythemia in 147 cases. Cancer 66:549\u2013556","journal-title":"Cancer"},{"key":"BF01788127_CR17","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1002\/ajmg.1320450426","volume":"45","author":"PJJ Genderen van","year":"1993","unstructured":"Genderen PJJ van, Michiels JJ, Drenth JPH (1993) Hereditary erythromelalgia and acquired erythromelalgia. Am J Med Gen 45:530\u2013531","journal-title":"Am J Med Gen"},{"key":"BF01788127_CR18","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0344-0338(11)81008-3","volume":"186","author":"A Georgii","year":"1990","unstructured":"Georgii A, Vykoupil KF, Buhr T, Choritz H, Dohler U, Kaloutsi V, Werner M (1990) Chronic myeloproliferative disorders in bone marrow biopsies. Pathol Res Pract 186:3\u201327","journal-title":"Pathol Res Pract"},{"key":"BF01788127_CR19","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0140-6736(88)90005-0","volume":"1","author":"FJ Giles","year":"1988","unstructured":"Giles FJ, Singer CRJ, Gray AG, Yong KL, Brozovic M, Davies SC, Grant IR, Hoffbrand AV, Machin SJ, Mehta AB, Richards JDM, Thomas MJG, Venutas S, Goldstone AH (1988) Alpha-interferon therapy for essential thrombocythaemia. Lancet 1:70\u201372","journal-title":"Lancet"},{"key":"BF01788127_CR20","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/S0140-6736(89)92142-9","volume":"2","author":"H Gisslinger","year":"1989","unstructured":"Gisslinger H, Ludwig H, Linkesch W, Chott A, Fritx E, Radaskiewicz Th (1989) Long-term interferon therapy for thrombocytosis in myeloproliferative diseases. Lancet 2:634\u2013637","journal-title":"Lancet"},{"key":"BF01788127_CR21","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1365-2257.1988.tb01168.x","volume":"10","author":"A Grossi","year":"1988","unstructured":"Grossi A, Rosseti S, Vannuchi AM, Rafanelli D, Ferrini PR (1988) Occurrence of haemorrhagic and thrombotic events in myeloproliferative disorders: a retrospective study of 108 patients. Clin Lab Haematol 10:167\u2013175","journal-title":"Clin Lab Haematol"},{"key":"BF01788127_CR22","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1365-2141.1989.tb04251.x","volume":"71","author":"L Gugliotta","year":"1989","unstructured":"Gugliotta L, Bagnara GP, Catani L, Gaggioli L, Guarini A, Zauli G, Belmonte MM, Lauria F, Macchi S, Tura S (1989) In vivo and in vitro inhibitory effect of alpha-interferon on megakaryocyte colony growth in essential thrombocythaemia. Br J Haematol 71:177\u2013181","journal-title":"Br J Haematol"},{"key":"BF01788127_CR23","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1182\/blood.V15.5.706.706","volume":"15","author":"FW Gunz","year":"1960","unstructured":"Gunz FW (1960) Hemorrhagic thrombocythemia: a critical review. Blood 15:706\u2013723","journal-title":"Blood"},{"key":"BF01788127_CR24","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1002\/1097-0142(19880615)61:12<2487::AID-CNCR2820611217>3.0.CO;2-T","volume":"61","author":"R Hehlmann","year":"1988","unstructured":"Hehlmann R, Jahn M, Baumann B, Kopcke W (1988) Essential thrombocythemia: clinical characteristics and course of 61 cases. Cancer 61:2487\u20132496","journal-title":"Cancer"},{"key":"BF01788127_CR25","first-page":"578","volume":"53","author":"HC Hoagland","year":"1978","unstructured":"Hoagland HC, Silverstein MN (1978) Primary thrombocythemia in the young patients. Mayo Clin Proc 53:578\u2013580","journal-title":"Mayo Clin Proc"},{"key":"BF01788127_CR26","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1600-0609.1990.tb00355.x","volume":"44","author":"J Kutti","year":"1990","unstructured":"Kutti J (1990) The management of thrombocytosis. Eur J Haematol 44:81\u201388","journal-title":"Eur J Haematol"},{"key":"BF01788127_CR27","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1002\/1097-0142(19880315)61:6<1207::AID-CNCR2820610625>3.0.CO;2-4","volume":"61","author":"JJ Lahuerta-Palacios","year":"1988","unstructured":"Lahuerta-Palacios JJ, Bornstein R, Fernandez-Debora FJ, Gutierrez-Rivas E, Ortiz MC, Laaregla S, Calandre L, Montero-Castillo J (1988) Controlled and uncontrolled thrombocytosis: its clinical role in essential thrombocythemia. Cancer 61:1207\u20131212","journal-title":"Cancer"},{"key":"BF01788127_CR28","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1600-0609.1988.tb00212.x","volume":"41","author":"E Lofvenberg","year":"1988","unstructured":"Lofvenberg E, Wahlin A (1988) Management of polycythaemia vera, essential thrombocythaemia and myelofibrosis with hydroxyurea. Eur J Haematol 41:375\u2013381","journal-title":"Eur J Haematol"},{"key":"BF01788127_CR29","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0165-4608(90)90164-6","volume":"49","author":"E Lofvenberg","year":"1990","unstructured":"Lofvenberg E, Nordenson I, Wahlin A (1990) Cytogenetic abnormalities and leukemic transformation in hydroxyureatreated patients with Philadelphia chromosome-negative chronic myeloproliferative disease. Cancer Genet Cytogenet 49:57\u201367","journal-title":"Cancer Genet Cytogenet"},{"key":"BF01788127_CR30","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1600-0609.1990.tb00344.x","volume":"44","author":"E Lofvenberg","year":"1990","unstructured":"Lofvenberg E, Wahlin A, Roos G, Ost A (1990) Reversal of myelofibrosis by hydroxyurea. Eur J Haematol 44:33\u201338","journal-title":"Eur J Haematol"},{"key":"BF01788127_CR31","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0025-6196(12)60486-8","volume":"66","author":"KJ McIntyre","year":"1991","unstructured":"McIntyre KJ, Hoagland HC, Silverstein MN, Petitt RM (1991) Essential thrombocythemia in young adults. Mayo Clin Proc 66:149\u2013155","journal-title":"Mayo Clin Proc"},{"key":"BF01788127_CR32","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1182\/blood.V79.8.1931.1931","volume":"79","author":"EM Mazur","year":"1992","unstructured":"Mazur EM, Rosmarin AG, Sohl PA, Newton JL, Narendran A (1992) Analysis of the mechanism of anagrelide-induced thrombocytopenia in humans. Blood 79:1931\u20131937","journal-title":"Blood"},{"key":"BF01788127_CR33","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1365-2141.1985.tb02880.x","volume":"61","author":"M Messinez","year":"1985","unstructured":"Messinez M, Pearson TC, Prochazka A, Wetherley-Mein G (1985) Treatment of primary proliferative polycythaemia by venesection and low-dose busulphan: retrospective study from one centre. Br J Haematol 61:657\u2013666","journal-title":"Br J Haematol"},{"key":"BF01788127_CR34","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0190-9622(08)80005-9","volume":"22","author":"JJ Michiels","year":"1990","unstructured":"Michiels JJ, van Joost T (1990) Erythromelalgia and thrombocythemia. A causal relation. J Am Acad Dermatol 22:107\u2013111","journal-title":"A causal relation. J Am Acad Dermatol"},{"key":"BF01788127_CR35","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/ajh.2830390211","volume":"39","author":"JJ Michiels","year":"1992","unstructured":"Michiels JJ, Ten Kate FWJ (1992) Erythromelalgia in thrombocythemia of various myeloproliferative disorders. Am J Hematol 39:131\u2013136","journal-title":"Am J Hematol"},{"key":"BF01788127_CR36","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/j.1365-2559.1984.tb02379.x","volume":"8","author":"JJ Michiels","year":"1985","unstructured":"Michiels JJ, Ten Kate FWJ, Vuzevski VD, Abels J (1985) Histopathology of erythromelalgia in thrombocythaemia. Histopathology 8:669\u2013678","journal-title":"Histopathology"},{"key":"BF01788127_CR37","doi-asserted-by":"crossref","first-page":"466","DOI":"10.7326\/0003-4819-102-4-466","volume":"102","author":"JJ Michiels","year":"1985","unstructured":"Michiels JJ, Abels J, Steketee J, van Vliet HHDM, Vuzevski VD (1985) Erythromelalgia caused by platelet-mediated arteriolar inflammation and thrombosis in thrombocythemia. Ann Intern Med 102:466\u2013471","journal-title":"Ann Intern Med"},{"key":"BF01788127_CR38","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1093\/ajcp\/88.5.645","volume":"88","author":"JJ Michiels","year":"1987","unstructured":"Michiels JJ, Prins MEF, Hagemeijer A, Brederoo P, van der Meulen J, van Vliet HHDM, Abels J (1987) Philadelphia chromosome-positive thrombocythemia and megakaryoblast leukemia. Am J Clin Pathol 88:645\u2013652","journal-title":"Am J Clin Pathol"},{"key":"BF01788127_CR39","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1212\/WNL.43.6.1107","volume":"43","author":"JJ Michiels","year":"1993","unstructured":"Michiels JJ, Koudstaal PJ, Mulder AH, van Vliet HHDM (1993) Transient neurological and ocular manifestations in primary thrombocythemia. Neurology 43:1107\u20131110","journal-title":"Neurology"},{"key":"BF01788127_CR40","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/ajh.2830330106","volume":"33","author":"FE Millard","year":"1990","unstructured":"Millard FE, Hunter CS, Anderson M, Edelman MJ, Kosty MP, Luiken GA, Marino GG (1990) Clinical manifestations of essential thrombocythemia in young adults. Am J Hematol 33:27\u201331","journal-title":"Am J Hematol"},{"key":"BF01788127_CR41","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/00000441-192310000-00001","volume":"166","author":"GR Minot","year":"1932","unstructured":"Minot GR, Buckman TE (1932) Erythremia (polycythemia rubra vera). Am J Med Sci 166:469\u2013489","journal-title":"Am J Med Sci"},{"key":"BF01788127_CR42","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0889-8588(18)30511-2","volume":"4","author":"AJ Mitus","year":"1990","unstructured":"Mitus AJ, Schafer AI (1990) Thrombocytosis and thrombocythemia. Hematol Oncol Clin N Am 4:157\u2013178","journal-title":"Hematol Oncol Clin N Am"},{"key":"BF01788127_CR43","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/0002-9343(90)90491-U","volume":"88","author":"AJ Mitus","year":"1990","unstructured":"Mitus AJ, Barbui T, Shulman LN, Rosenthal DS, Viero P, Cortelazzo S, Schafer AI (1990) Hemostatic complications in young patients with essential thrombocythemia. Am J Med 88:371\u2013375","journal-title":"Am J Med"},{"key":"BF01788127_CR44","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1365-2141.1988.tb02427.x","volume":"70","author":"CM Morris","year":"1988","unstructured":"Morris CM, Fitzgerald PH, Hollings PE, Archer SA, Rosman I, Beard MEJ (1988) Essential thrombocythaemia and the Philadelphia chromosome. Br J Haematol 70:13\u201319","journal-title":"Br J Haematol"},{"key":"BF01788127_CR45","first-page":"177","volume":"23","author":"S Murphy","year":"1986","unstructured":"Murphy S, Iland H, Rosenthal D, Laszlo J (1986) Essential thrombocythemia: an interim report from the Polycythemia Vera Study Group. Semin Hematol 23:177\u2013182","journal-title":"Semin Hematol"},{"key":"BF01788127_CR46","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1365-2141.1991.tb04408.x","volume":"78","author":"TC Pearson","year":"1991","unstructured":"Pearson TC (1991) Primary thrombocythaemia: diagnosis and management. Br J Haematol 78:145\u2013148","journal-title":"Br J Haematol"},{"key":"BF01788127_CR47","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1365-2141.1986.tb02926.x","volume":"62","author":"JEW Pette van de","year":"1986","unstructured":"Pette JEW van de, Prochazka AV, Pearson TC, Singh AK, Dickson ER, Wetherley-Mein G (1986) Primary thrombocythaemia treated with busulphan. Br J Haematol 62:229\u2013237","journal-title":"Br J Haematol"},{"key":"BF01788127_CR48","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/BF01728790","volume":"60","author":"ML Randi","year":"1990","unstructured":"Randi ML, Fabris F, Girolami A (1990) Thrombocytosis in young people: evaluation of 57 cases diagnosed before the age of 40. Blut 60:233\u2013237","journal-title":"Blut"},{"key":"BF01788127_CR49","first-page":"213","volume":"22","author":"ML Randi","year":"1991","unstructured":"Randi ML, Stocco F, Rossi C, Tison T, Girolami A (1991) Thrombosis and hemorrhage in thrombocytosis: evaluation of a large cohort of patients (357 cases). J Med 22:213\u2013223","journal-title":"J Med"},{"key":"BF01788127_CR50","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/BF01703444","volume":"63","author":"S Sacchi","year":"1991","unstructured":"Sacchi S, Tabilio A, Leoni P, Riccardi A, Vecchi A, Messora C, Falzetti F, Rupoli S, Ucci G, Martelli MF (1991) Interferon alpha-2b in the long-term treatment of essential thrombocythemia. Ann Hematol 63:206\u2013209","journal-title":"Ann Hematol"},{"key":"BF01788127_CR51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/blood.V64.1.1.1","volume":"64","author":"AI Schafer","year":"1984","unstructured":"Schafer AI (1984) Bleeding and thrombosis in the myeloproliferative disorders. Blood 64:1\u201312","journal-title":"Blood"},{"key":"BF01788127_CR52","first-page":"69","volume":"10","author":"AI Schafer","year":"1991","unstructured":"Schafer AI (1991) Essential thrombocythemia. Prog Hemost Thromb 10:69\u201396","journal-title":"Prog Hemost Thromb"},{"key":"BF01788127_CR53","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/0002-8703(91)91019-J","volume":"122","author":"MG Scheffer","year":"1991","unstructured":"Scheffer MG, Michiels JJ, Simoons ML, Roelandt JRTC (1991) Thrombocythemia and coronary artery disease. Am Heart J 122:573\u2013576","journal-title":"Am Heart J"},{"key":"BF01788127_CR54","first-page":"767","volume":"243","author":"S Seiler","year":"1987","unstructured":"Seiler S, Arnold AJ, Grove RI, Fifer CA, Keely SL, Stanton HC (1987) Effects of anagrelide on platelet cAMP levels, cAMP-dependent protein kinase and thrombin-induced Ca++ fluxes. J Pharmacol Exp Ther 243:767\u2013774","journal-title":"J Pharmacol Exp Ther"},{"key":"BF01788127_CR55","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/j.1365-2141.1977.tb00996.x","volume":"36","author":"AK Singh","year":"1977","unstructured":"Singh AK, Wetherley-Mein G (1977) Microvascular occlusive lesions in primary thrombocythaemia. Br J Haematol 36:553\u2013564","journal-title":"Br J Haematol"},{"key":"BF01788127_CR56","first-page":"172","volume":"23","author":"AP Tartaglia","year":"1986","unstructured":"Tartaglia AP, Goldberg JD, Berk PD, Wasserman LR (1986) Adverse effects of antiaggregating platelet therapy in the treatment of polycythemia vera. Semin Hematol 23:172\u2013176","journal-title":"Semin Hematol"},{"key":"BF01788127_CR57","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/00005792-197109000-00001","volume":"50","author":"HP Ward","year":"1971","unstructured":"Ward HP, Block MH (1971) The natural history of agnogenic myeloid metaplasia and a critical evaluation of its relationship with the myeloproliferative syndromes. Medicine 50:357\u2013419","journal-title":"Medicine"},{"key":"BF01788127_CR58","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1365-2141.1993.tb08272.x","volume":"83","author":"KV Watson","year":"1993","unstructured":"Watson KV, Key N (1993) Vascular complications of essential thrombocythaemia: a link to cardiovascular risk factors. Br J Haematol 83:198\u2013203","journal-title":"Br J Haematol"},{"key":"BF01788127_CR59","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/BF01707281","volume":"63","author":"A Wehmeier","year":"1991","unstructured":"Wehmeier A, Daum I, Jamin H, Schneider W (1991) Incidence and clinical risk factors for bleeding and thrombotic complications in myeloproliferative disorders: a retrospective analysis of 260 patients. Ann Hematol 63:101\u2013106","journal-title":"Ann Hematol"},{"key":"BF01788127_CR60","first-page":"1","volume":"67","author":"EA Willebrand von","year":"1926","unstructured":"Willebrand von EA (1926) Heredit\u00e4r pseudohemofili. Finska Lakarsallskapets Handlingar 67:1\u201312","journal-title":"Finska Lakarsallskapets Handlingar"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01788127.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01788127\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01788127","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T21:05:48Z","timestamp":1586293548000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01788127"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,8]]},"references-count":60,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1993,8]]}},"alternative-id":["BF01788127"],"URL":"https:\/\/doi.org\/10.1007\/bf01788127","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[1993,8]]}}}